Burkitt's Lymphoma: Differential Killing of Epstein-Barr Virus (EBV) (+) and EBV(-) Burkitt Lymphoma Cells in Vitro and Dose-Dependent Lytic Induction by Bortezomib in Vivo
Infectious Agents and Cancer - United Kingdom
doi 10.1186/1750-9378-4-s2-p16
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2009
Authors
Publisher
Springer Science and Business Media LLC